Single‐Cell Analysis Reveals that Vitamin C Inhibits Bone Metastasis of Renal Cancer via Cell Cycle Arrest and Microenvironment Remodeling
Authors:
Open Access
- 28 May 2025
- journal article
- Published by Wiley in Advanced Science
- Vol. 12 (30) , e01011
Abstract
Bone metastasis is the second most common site of distant metastatic spread in renal cell carcinoma (RCC) patients, significantly contributing to cancer‐related mortality. The metastatic process is driven by both intrinsic tumor cell properties, such as cancer stem cell‐like characteristics, and the bone microenvironment. Understanding the complex interactions between cancer cells and their niche is crucial for identifying therapeutic targets to eliminate metastasis‐initiating cells and prevent overt metastasis. In this study, a murine bone metastasis model is developed using renal cancer cells derived from fibrin gel‐induced 3D tumor spheres, which exhibit stem‐like phenotypes. It is found that a stable form of vitamin C, L‐ascorbic acid 2‐phosphate sesquimagnesium (APM), significantly inhibits the growth of renal cancer stem‐like cells in vitro and the progression of RCC bone metastasis in vivo. Single‐cell RNA sequencing revealed that APM induces cell cycle arrest and reduces the metastatic potential of cancer cells. Furthermore, APM remodels the tumor microenvironment by suppressing osteoclast differentiation and neutrophil recruitment. Combining APM with a CXCR2 antagonist, SB225002, further inhibits bone metastasis progression. This study provides a high‐resolution profile of vitamin C's antitumor effects in the bone metastatic microenvironment and supports the rationale for clinical trials of vitamin C in bone metastatic RCC.Keywords
Funding Information
- Natural Science Foundation of Beijing Municipality (J230017)
- Natural Science Foundation of Beijing Municipality (L248017)
- National Natural Science Foundation of China (82173216)
- National Natural Science Foundation of China (82372951)
- National Natural Science Foundation of China (82341030)
- Capital Health Research and Development of Special Fund (2022‐1‐4072)
This publication has 92 references indexed in Scilit:
- Multifaceted roles of neutrophils in tumor microenvironmentBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2024
- Characterization and Function of Tumor Necrosis Factor and Interleukin‐6–Induced Osteoclasts in Rheumatoid ArthritisArthritis & Rheumatology, 2021
- Epigenetic dynamics in cancer stem cell dormancyCancer and Metastasis Reviews, 2020
- Opposing effects of low versus high concentrations of water soluble vitamins/dietary ingredients Vitamin C and niacin on colon cancer stem cells (CSCs)Cell Biology International, 2017
- Marrow adipocyte-derived CXCL1 and CXCL2 contribute to osteolysis in metastatic prostate cancerClinical & Experimental Metastasis, 2015
- Phase I clinical trial to evaluate the safety, tolerability, and pharmacokinetics of high-dose intravenous ascorbic acid in patients with advanced cancerCancer Chemotherapy and Pharmacology, 2013
- Vitamin C down‐regulates VEGF production in B16F10 murine melanoma cells via the suppression of p42/44 MAPK activationJournal of Cellular Biochemistry, 2010
- A novel targeting modality for renal cell carcinoma: human osteocalcin promoter‐mediated gene therapy synergistically induced by vitamin C and vitamin D3The Journal of Gene Medicine, 2010
- Breast cancer cells with inhibition of p38<>α have decreased MMP-9 activity and exhibit decreased bone metastasis in miceClinical & Experimental Metastasis, 2004
- The role of fibrin in tumor metastasisCancer and Metastasis Reviews, 1992